First Trust Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128M | Buy |
|
|||||
|
2025
Q1 | $70.2M | Sell |
|
|||||
|
2024
Q4 | $77.6M | Sell |
|
|||||
|
2024
Q3 | $267M | Buy |
|
|||||
|
2024
Q2 | $95.3M | Sell |
|
|||||
|
2024
Q1 | $96.6M | Sell |
|
|||||
|
2023
Q4 | $299M | Sell |
|
|||||
|
2023
Q3 | $278M | Buy |
|
|||||
|
2023
Q2 | $102M | Sell |
|
|||||
|
2023
Q1 | $105M | Sell |
|
|||||
|
2022
Q4 | $101M | Sell |
|
|||||
|
2022
Q3 | $104M | Sell |
|
|||||
|
2022
Q2 | $290M | Buy |
|
|||||
|
2022
Q1 | $115M | Sell |
|
|||||
|
2021
Q4 | $115M | Buy |
|
|||||
|
2021
Q3 | $89M | Buy |
|
|||||
|
2021
Q2 | $80.5M | Buy |
|
|||||
|
2021
Q1 | $83.3M | Sell |
|
|||||
|
2020
Q4 | $95.5M | Sell |
|
|||||
|
2020
Q3 | $226M | Buy |
|
|||||
|
2020
Q2 | $236M | Buy |
|
|||||
|
2020
Q1 | $118M | Buy |
|
|||||
|
2019
Q4 | $78.2M | Sell |
|
|||||
|
2019
Q3 | $75.6M | Sell |
|
|||||
|
2019
Q2 | $123M | Sell |
|
|||||
|
2019
Q1 | $136M | Buy |
|
|||||
|
2018
Q4 | $117M | Sell |
|
|||||
|
2018
Q3 | $138M | Buy |
|
|||||
|
2018
Q2 | $87.3M | Buy |
|
|||||
|
2018
Q1 | $77.7M | Sell |
|
|||||
|
2017
Q4 | $81.3M | Sell |
|
|||||
|
2017
Q3 | $84.4M | Sell |
|
|||||
|
2017
Q2 | $83.3M | Buy |
|
|||||
|
2017
Q1 | $44.1M | Sell |
|
|||||
|
2016
Q4 | $30.7M | Buy |
|
|||||
|
2016
Q3 | $31.4M | Sell |
|
|||||
|
2016
Q2 | $35.8M | Sell |
|
|||||
|
2016
Q1 | $34.5M | Sell |
|
|||||
|
2015
Q4 | $123M | Sell |
|
|||||
|
2015
Q3 | $107M | Buy |
|
|||||
|
2015
Q2 | $124M | Buy |
|
|||||
|
2015
Q1 | $100M | Sell |
|
|||||
|
2014
Q4 | $121M | Buy |
|
|||||
|
2014
Q3 | $99.2M | Sell |
|
|||||
|
2014
Q2 | $93.4M | Buy |
|
|||||
|
2014
Q1 | $55.7M | Buy |
|
|||||
|
2013
Q4 | $47.1M | Sell |
|
|||||
|
2013
Q3 | $50.1M | Buy |
|
|||||
|
2013
Q2 | $32.7M | Buy |
|